Agios Pharmaceuticals (AGIO) Current Deferred Tax Assets (2012 - 2013)

Agios Pharmaceuticals (AGIO) posted Current Deferred Tax Assets of $1.2 million for Q3 2013, little changed on a QoQ basis from $1.2 million in Q2 2013.

Agios Pharmaceuticals (AGIO) Current Deferred Tax Assets (2012 - 2013) Analysis & Trends

Agios Pharmaceuticals' Current Deferred Tax Assets history runs 2 years deep, the most recent figure standing at $1.2 million for Q3 2013.

  • Quarterly Current Deferred Tax Assets changed N/A year-over-year to $1.2 million in Q3 2013, while the trailing twelve-month figure through Sep 2013 was $1.2 million (changed N/A YoY) and the FY2012 annual result came in at $1.2 million, changed N/A from the prior year.
  • Current Deferred Tax Assets was $1.2 million for Q3 2013 at Agios Pharmaceuticals, roughly flat from $1.2 million in the prior quarter.
  • Across five years, Current Deferred Tax Assets topped out at $1.2 million in Q2 2013 and bottomed at $1.2 million in Q4 2012.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Agios Pharmaceuticals 2.13 Bn 2.13 Bn 19.43 Mn

Historic Data

Download Data
DateValue
Sep 30, 2013 1.25 Mn
Sep 30, 2013 1.25 Mn
Jun 30, 2013 1.25 Mn
Jun 30, 2013 1.25 Mn
Dec 31, 2012 1.25 Mn
Dec 31, 2012 1.25 Mn